Inventor
SCHNECK JONATHAN
US14 patents
Patents
14 patentsUS6268411B1Jul 31, 2001
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
UNIV JOHNS HOPKINS95 citations94
US6015884AJan 18, 2000
Soluble divalent and multivalent heterodimeric analogs of proteins
UNIV JOHNS HOPKINS80 citations94
US6458354B1Oct 1, 2002
Molecular complexes which modify immune responses
UNIV JOHNS HOPKINS28 citations91
US6448071B1Sep 10, 2002
Soluble divalent and multivalent heterodimeric analogs of proteins
UNIV JOHNS HOPKINS35 citations91
US6140113AOct 31, 2000
Polynucleotides encoding molecular complexes which modify immune responses
UNIV JOHNS HOPKINS45 citations91
US6734013B2May 11, 2004
Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
UNIV JOHNS HOPKINS27 citations89
US7973137B1Jul 5, 2011
Cell compositions comprising molecular complexes that modify immune responses
UNIV JOHNS HOPKINS8 citations82
US10987412B2Apr 27, 2021
Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells
UNIV JOHNS HOPKINS3 citations68
US10098939B2Oct 16, 2018
Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells
UNIV JOHNS HOPKINS5 citations68
US11939595B2Mar 26, 2024
Nanoscale artificial antigen presenting cells
UNIV JOHNS HOPKINS0 citations59
US10435668B2Oct 8, 2019
Nanoscale artificial antigen presenting cells
UNIV JOHNS HOPKINS1 citations59
US12059476B2Aug 13, 2024
Biodegradable biomimetic particles
UNIV JOHNS HOPKINS0 citations53
US10463750B2Nov 5, 2019
Antigen-Specific T cell redirectors
UNIV JOHNS HOPKINS0 citations50
US10758487B2Sep 1, 2020
Artificial antigen presenting cells having a defined and dynamic shape
UNIV JOHNS HOPKINS0 citations38